Munich, Germany

Georg Nesemann

This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 1976.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Georg Nesemann: Innovator in Moenomycin Preparation

Introduction

Georg Nesemann is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the preparation of moenomycin. His innovative approach has led to advancements in the fermentation processes used in pharmaceutical applications.

Latest Patents

Nesemann holds a patent for a process for the preparation of moenomycin. This process involves the aerobic fermentation of moenomycin-forming Streptomyces in the presence of fats, with an improvement that includes a surfactant of a specific formula. His work in this area has the potential to enhance the efficiency and effectiveness of moenomycin production.

Career Highlights

Throughout his career, Georg Nesemann has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His role at Hoechst has allowed him to focus on innovative research and development, contributing to the advancement of biotechnological processes.

Collaborations

Nesemann has collaborated with notable colleagues, including Jurgen Dietrich and Dieter Sukatsch. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.

Conclusion

Georg Nesemann's contributions to the preparation of moenomycin highlight his innovative spirit and dedication to advancing biotechnological processes. His work continues to influence the pharmaceutical industry and showcases the importance of research and collaboration in driving innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…